Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (8) , 1206-1212
- https://doi.org/10.1023/a:1018941328702
Abstract
Purpose. To determine the role of P-glycoprotein (Pgp) on the CNS penetration of the HIV protease inhibitor (PI) amprenavir (141W94) and to test the hypothesis that co-administration of a second HIV...Keywords
This publication has 22 references indexed in Scilit:
- In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral AgentsJournal of Pharmaceutical Sciences, 1998
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- AmprenavirDrugs, 1998
- Characterization of Phosphine Complexes of Technetium(III) as Transport Substrates of the Multidrug Resistance P-Glycoprotein and Functional Markers of P-Glycoprotein at the Blood−Brain BarrierBiochemistry, 1997
- Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virusClinical Therapeutics, 1997
- Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRPAnti-Cancer Drugs, 1997
- HIV protease inhibitorsAIDS, 1996
- Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus TherapyThe Journal of Infectious Diseases, 1995
- Review of Antiretroviral Therapy in the Prevention of HIV-Related AIDS Dementia Complex (ADC)Drugs, 1995